J. Goldman & Co LP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$856,000
-78.3%
26,780
-76.5%
0.04%
-76.7%
Q1 2022$3,952,000
+121.0%
114,092
+237.7%
0.18%
+78.2%
Q1 2019$1,788,000
+28.7%
33,789
-0.2%
0.10%
-5.6%
Q4 2018$1,389,000
+64.4%
33,844
+93.4%
0.11%
+197.2%
Q1 2018$845,000
-47.3%
17,500
-70.1%
0.04%
-58.6%
Q2 2017$1,603,000
+55.6%
58,600
-5.6%
0.09%
+61.1%
Q2 2016$1,030,00062,1000.05%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2018
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders